Arthritis Res Ther. 2011 Jul 6;13(4):228.

Cytokine disturbances in systemic lupus erythematosus.

Source

Division of Rheumatology, Department of Medicine, University of Southern California Keck School of Medicine, 2011 Zonal Ave, HMR 711, Los Angeles, CA 90033, USA.

Abstract

The pathogenesis of systemic lupus erythematosus (SLE) is complex, and the resulting disease manifestations are heterogeneous. Cytokine dysregulation is pervasive, and their protein and gene expression profiles may serve as markers of disease activity and severity. Importantly, biologic agents that target specific cytokines may represent novel therapies for SLE. Four cytokines (IL-6, TNFα, IFNα, and BLyS) are being evaluated as therapeutic targets in SLE. The present review will examine the roles of each of these cytokines in murine and human SLE, and will summarize results from clinical trials of agents that target these cytokines.

PMID:: 21745419; [PubMed - indexed for MEDLINE]
PMCID:: PMC3239336

Free PMC Article

LinkOut - more resources

Full Text Sources

Medical

Lupus - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. [Arthritis Rheum. 2009]
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, et al. Arthritis Rheum. 2009 Jun; 60(6):1785-96.
Review [Cytokine blockade - a promising therapeutic option in SLE]. [Z Rheumatol. 2008]
Review [Cytokine blockade - a promising therapeutic option in SLE].
Aringer M, Feierl E, Smolen J. Z Rheumatol. 2008 Jul; 67(4):315-7.
Review Treatment of systemic lupus erythematosus: new advances in targeted therapy. [Ann N Y Acad Sci. 2012]
Review Treatment of systemic lupus erythematosus: new advances in targeted therapy.
Lo MS, Tsokos GC. Ann N Y Acad Sci. 2012 Jan; 1247:138-52. Epub 2012 Jan 11.
Review BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists. [Curr Dir Autoimmun. 2005]
Review BlySfulness does not equal blissfulness in systemic lupus erythematosus: a therapeutic role for BLyS antagonists.
Stohl W. Curr Dir Autoimmun. 2005; 8:289-304.
Review Cytokines as therapeutic targets in SLE. [Nat Rev Rheumatol. 2010]
Review Cytokines as therapeutic targets in SLE.
Rönnblom L, Elkon KB. Nat Rev Rheumatol. 2010 Jun; 6(6):339-47. Epub 2010 May 4.

See reviews... See all...

Cited by 1 PubMed Central article

Challenges in understanding Sjögren's syndrome--improved insights into the pathogenesis generate hope for innovative therapies? [Arthritis Res Ther. 2011]
Challenges in understanding Sjögren's syndrome--improved insights into the pathogenesis generate hope for innovative therapies?
Dörner T. Arthritis Res Ther. 2011 Aug 19; 13(4):123. Epub 2011 Aug 19.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cytokine disturbances in systemic lupus erythematosus.
Cytokine disturbances in systemic lupus erythematosus.
Arthritis Res Ther. 2011 Jul 6 ;13(4):228.

PubMed
Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygen...
Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis.
J Biol Chem. 1990 Nov 15 ;265(32):19818-23.

PubMed
Renal co-morbidity in patients with rheumatic diseases.
Renal co-morbidity in patients with rheumatic diseases.
Arthritis Res Ther. 2011 Jun 29 ;13(3):222.

PubMed
Antiarthritic activity of the newly developed neutrophil oxidative burst antagon...
Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin.
Free Radic Biol Med. 1990 ;9(2):127-31.

PubMed
Identification of target antigens of anti-endothelial cell and anti-vascular smo...
Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.
Arthritis Res Ther. 2011 Jun 28 ;13(3):R107.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cytokine disturbances in systemic lupus erythematosus.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information